Active Biotech (Sweden) Probability of Future Stock Price Finishing Over 0.8
| ACTI Stock | SEK 0.26 0.01 4.00% |
Active |
Active Biotech Target Price Odds to finish over 0.8
The tendency of Active Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over kr 0.80 or more in 90 days |
| 0.26 | 90 days | 0.80 | near 1 |
Based on a normal probability distribution, the odds of Active Biotech to move over kr 0.80 or more in 90 days from now is near 1 (This Active Biotech AB probability density function shows the probability of Active Stock to fall within a particular range of prices over 90 days) . Probability of Active Biotech AB price to stay between its current price of kr 0.26 and kr 0.80 at the end of the 90-day period is about 61.99 .
Assuming the 90 days trading horizon Active Biotech AB has a beta of -4.75. This suggests as returns on its benchmark rise, returns on holding Active Biotech AB are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Active Biotech is expected to outperform its benchmark. Moreover Active Biotech AB has an alpha of 1.9844, implying that it can generate a 1.98 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Active Biotech Price Density |
| Price |
Predictive Modules for Active Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Active Biotech AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Active Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Active Biotech is not an exception. The market had few large corrections towards the Active Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Active Biotech AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Active Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.98 | |
β | Beta against Dow Jones | -4.75 | |
σ | Overall volatility | 0.1 | |
Ir | Information ratio | 0.05 |
Active Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Active Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Active Biotech AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Active Biotech AB is way too risky over 90 days horizon | |
| Active Biotech AB has some characteristics of a very speculative penny stock | |
| Active Biotech AB appears to be risky and price may revert if volatility continues | |
| Active Biotech AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (49.83 M) with profit before overhead, payroll, taxes, and interest of 6.72 M. | |
| Active Biotech AB has accumulated about 53.13 M in cash with (46.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 46.0% of the company shares are held by company insiders |
Active Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Active Stock often depends not only on the future outlook of the current and potential Active Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Active Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 211.9 M | |
| Cash And Short Term Investments | 53.1 M |
Active Biotech Technical Analysis
Active Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Active Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Active Biotech AB. In general, you should focus on analyzing Active Stock price patterns and their correlations with different microeconomic environments and drivers.
Active Biotech Predictive Forecast Models
Active Biotech's time-series forecasting models is one of many Active Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Active Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Active Biotech AB
Checking the ongoing alerts about Active Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Active Biotech AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Active Biotech AB is way too risky over 90 days horizon | |
| Active Biotech AB has some characteristics of a very speculative penny stock | |
| Active Biotech AB appears to be risky and price may revert if volatility continues | |
| Active Biotech AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (49.83 M) with profit before overhead, payroll, taxes, and interest of 6.72 M. | |
| Active Biotech AB has accumulated about 53.13 M in cash with (46.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 46.0% of the company shares are held by company insiders |
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.